NCT06840925View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

May 30, 2025

Study Completion Date

June 30, 2025

Conditions
Healthy
Interventions
DRUG

PRAX-628

Once daily oral

Trial Locations (1)

3004

Nucleus Network Melbourne, Melbourne

Sponsors
All Listed Sponsors
lead

Praxis Precision Medicines

INDUSTRY

NCT06840925 - A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628 | Biotech Hunter | Biotech Hunter